Venture capital investment in biopharmaceutical companies totaled $9.7bn in the first half of this year, so if the pace of $4.8bn per quarter keeps up, 2018 will beat the $12.4bn invested in private drug development firms in 2017 before the end of the third quarter.
PitchBook and the National Venture Capital Association (NVCA) noted several trends behind soaring venture capital investment in their quarterly Venture...